Literature DB >> 19546771

Human papillomavirus infection: a concise review of natural history.

Warner K Huh1.   

Abstract

Persistent infection with oncogenic human papillomavirus (HPV), leading to precancerous lesions and potentially cervical cancer, is a serious health burden. The natural history of infection is one that enables the virus to remain immunoevasive within the cervical epithelium and persist for decades. Many studies have provided important information on why some women clear infection and why others do not. The infectious process of HPV may be affected by many cofactors, adding to the complexity of disease development. Vaccination against oncogenic HPV along with cervical screening are two methods that have been developed to provide protection and eliminate the overall burden of disease in women. This article highlights the natural history of oncogenic HPV infection of the cervix and the limitations that currently exist on the literature.

Entities:  

Mesh:

Year:  2009        PMID: 19546771     DOI: 10.1097/AOG.0b013e3181ab6878

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  19 in total

1.  Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil.

Authors:  Mary C Cambou; Paula M Luz; Jordan E Lake; José Eduardo Levi; José Ricardo Coutinho; Angela de Andrade; Thais Heinke; Mônica Derrico; Valdilea G Veloso; Ruth K Friedman; Beatriz Grinsztejn
Journal:  AIDS Patient Care STDS       Date:  2015-01       Impact factor: 5.078

2.  Local inflammation and human papillomavirus status of head and neck cancers.

Authors:  Mine Tezal; Frank A Scannapieco; Jean Wactawski-Wende; Andrew Hyland; James R Marshall; Nestor R Rigual; Daniel L Stoler
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-07

Review 3.  Perspective for prophylaxis and treatment of cervical cancer: an immunological approach.

Authors:  Marjorie Jenkins; Maurizio Chiriva-Internati; Leonardo Mirandola; Catherine Tonroy; Sean S Tedjarati; Nicole Davis; Nicholas D'Cunha; Lukman Tijani; Fred Hardwick; Diane Nguyen; W Martin Kast; Everardo Cobos
Journal:  Int Rev Immunol       Date:  2012-02       Impact factor: 5.311

4.  Characteristics of bacterial vaginosis infection in cervical lesions with high risk human papillomavirus infection.

Authors:  Huan Lu; Peng-Cheng Jiang; Xiao-Dan Zhang; Wen-Jing Hou; Zhen-Hong Wei; Jia-Qi Lu; Hao Zhang; Guang-Xu Xu; Yuan-Ping Chen; Yuan Ren; Li Wang; Rong Zhang; Ying Han
Journal:  Int J Clin Exp Med       Date:  2015-11-15

5.  The significant diagnostic value of human telomerase RNA component (hTERC) gene detection in high-grade cervical lesions and invasive cancer.

Authors:  Xiaobin Wang; Jia Liu; Hong Xi; Liping Cai
Journal:  Tumour Biol       Date:  2014-04-16

Review 6.  Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and meta-analysis.

Authors:  Evy Gillet; Joris F A Meys; Hans Verstraelen; Rita Verhelst; Philippe De Sutter; Marleen Temmerman; Davy Vanden Broeck
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

7.  Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis.

Authors:  Evy Gillet; Joris Fa Meys; Hans Verstraelen; Carolyne Bosire; Philippe De Sutter; Marleen Temmerman; Davy Vanden Broeck
Journal:  BMC Infect Dis       Date:  2011-01-11       Impact factor: 3.090

8.  Interaction between Chronic Inflammation and Oral HPV Infection in the Etiology of Head and Neck Cancers.

Authors:  Mine Tezal
Journal:  Int J Otolaryngol       Date:  2012-02-23

Review 9.  Bacterial immunotherapy of gastrointestinal tumors.

Authors:  Michael Linnebacher; Claudia Maletzki; Ulrike Klier; Ernst Klar
Journal:  Langenbecks Arch Surg       Date:  2011-12-22       Impact factor: 3.445

10.  Risk of vertical transmission of human papillomavirus throughout pregnancy: a prospective study.

Authors:  Seung Mi Lee; Joong Shin Park; Errol R Norwitz; Ja Nam Koo; Ig Hwan Oh; Jeong Woo Park; Sun Min Kim; Yun Hwan Kim; Chan-Wook Park; Yong Sang Song
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.